Why is early provision of balanced blood products important in massive hemorrhage, and what ratio is commonly used?

Prepare for the Advanced Trauma Care for Nurses (ATCN) Exam. Utilize flashcards and multiple choice questions, each with hints and explanations. Ensure readiness for your exam day!

Multiple Choice

Why is early provision of balanced blood products important in massive hemorrhage, and what ratio is commonly used?

Explanation:
Early provision of balanced blood products in massive hemorrhage aims to prevent dilutional coagulopathy and improve survival. When large volumes of red blood cells are given without adequate plasma and platelets, the patient’s clotting factors and platelet function become diluted and depleted, so bleeding continues even as anemia is corrected. Providing plasma delivers clotting factors, and platelets restore primary hemostasis, helping to form stable clots while red cells maintain oxygen delivery to tissues. Using these components together early supports both hemostasis and perfusion, which is why a 1:1:1 ratio of red blood cells to plasma to platelets (or close equivalents) is commonly used to approximate whole blood and optimize outcomes in massive transfusion. Other strategies that reduce plasma or focus solely on red cells don’t address the coagulopathy and can worsen bleeding.

Early provision of balanced blood products in massive hemorrhage aims to prevent dilutional coagulopathy and improve survival. When large volumes of red blood cells are given without adequate plasma and platelets, the patient’s clotting factors and platelet function become diluted and depleted, so bleeding continues even as anemia is corrected. Providing plasma delivers clotting factors, and platelets restore primary hemostasis, helping to form stable clots while red cells maintain oxygen delivery to tissues. Using these components together early supports both hemostasis and perfusion, which is why a 1:1:1 ratio of red blood cells to plasma to platelets (or close equivalents) is commonly used to approximate whole blood and optimize outcomes in massive transfusion. Other strategies that reduce plasma or focus solely on red cells don’t address the coagulopathy and can worsen bleeding.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy